50% of dementia sufferers are undiagnosed and many are misdiagnosed

By 2050, 152 million people around the world will have Dementia

Disease Prevalence
Disease Prevalence

By 2050, 152 million people around the world will have Dementia

press to zoom
Alzheimer's Drug Discovery
Alzheimer's Drug Discovery

More than 200 experimental drugs have failed in clinical trials.

press to zoom
Dementia Diagnosis
Dementia Diagnosis

50% of dementia sufferers are undiagnosed and many are misdiagnosed

press to zoom
Disease Prevalence
Disease Prevalence

By 2050, 152 million people around the world will have Dementia

press to zoom
1/5

Dementia - A Global Healthcare Crisis

Oxford Brain Diagnostics' breakthrough technology aims to change the way Dementia is assessed.

Our technology Cortical Disarray Measurement seeks to bring hope to patients, clinicians and pharmaceutical companies by offering greater certainty in Alzheimer's disease diagnosis at the earliest opportunity.

We are committed to providing early diagnosis, disease prediction and progression tracking as clinical services. Our innovative technology strives to deliver products globally to patients.